http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29498403

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 199
issn 1470-269X
1473-1150
issueIdentifier 3
pageRange 194-199
publicationName The Pharmacogenomics Journal
startingPage 194
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_aa03da85ff467e5b74053aee007a7c1a
bibliographicCitation Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini WH, Lerman C. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics J. 2006 May;6(3):194–9. doi: 10.1038/sj.tpj.6500358. PMID: 16402081.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4cd4e9a90c9afa411d316a80c6cbd20
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91f891809548b83344e2bdde57c07701
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6e4006a00852fca11bf25de47692c74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_607db0f16f57f81f99ab3685c9a00073
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6e30ba76f6cc2e8f77eeced538dda5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12667f6aea8db289f0c6ee24ce88089a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd23cb39dfd540c7a2311177ec5d52d5
date 2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.tpj.6500358
https://pubmed.ncbi.nlm.nih.gov/16402081
isPartOf https://portal.issn.org/resource/ISSN/1470-269X
https://portal.issn.org/resource/ISSN/1473-1150
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22416
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence
discusses http://id.nlm.nih.gov/mesh/M0026473
http://id.nlm.nih.gov/mesh/M0014836
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9438
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ec7d10ad0fb46d4e2cf5c7aa54334b01
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a20a852de6e0b3ecac342b0499ddb5b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261213
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23413

Total number of triples: 42.